Vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 10, 2016, Pages e82-e86

  Majesky, Mark W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

aneurysm; atherosclerosis; collagen; elastin; smooth muscle

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN; CYTOKINE; ELASTIN; HEAT SHOCK PROTEIN 27; MYOCARDIN; SERUM RESPONSE FACTOR; TRANSFORMING GROWTH FACTOR BETA; ACTIN;

ACTIN POLYMERIZATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL MIGRATION; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; INTERNAL MAMMARY ARTERY; MACROPHAGE; NEOINTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTIC ANEURYSM; EMBRYOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERIZATION; SMOOTH MUSCLE CELL; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; AORTIC ANEURYSM; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; POLYMERIZATION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR REMODELING;

EID: 84988650895     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.308261     Document Type: Article

References (77)

1. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
2. Majesky MW, Dong XR, Regan JN, Hoglund VJ. Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ Res 2011;108:365-377. doi:10.1161/CIRCRESAHA.110.223800.
3. Gomez D, Swiatlowska P, Owens GK. Epigenetic control of smooth muscle cell identity and lineage memory. Arterioscler Thromb Vasc Biol. 2015;35:2508-2516. doi: 10.1161/ATVBAHA.115.305044.
4. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957-989. doi: 10.1152/physrev.00041.2008.
5. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001;105:851-862.
6. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705-710. doi: 10.1038/nature08195.
7. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol. 2010;30:1118-1126. doi: 10.1161/ATVBAHA.109.200873.
8. Pellegrini L, Tan S, Richmond TJ. Structure of serum response factor core bound to DNA. Nature. 1995;376:490-498. doi: 10.1038/376490a0.
9. Gramzow L, Ritz MS, Theissen G. On the origin of MADS-domain transcription factors. Trends Genet. 2010;26:149-153. doi: 10.1016/j. Tig.2010.01.004.
10. Han Z, Li X, Wu J, Olson EN. A myocardin-related transcription factor regulates activity of serum response factor in Drosophila. Proc Natl Acad Sci USA. 2004;101:12567-12572. doi: 10.1073/pnas.0405085101.
11. Wang DZ, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev. 2004;14:558-566. doi: 10.1016/j.gde.2004.08.003.
12. Miano JM. Myocardin in biology and disease. J Biomed Res. 2015;29:3-19. doi: 10.7555/JBR.29.20140151.
13. Rong JX, Shapiro M, Trogan E, Fisher EA. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA. 2003;100:13531-13536. doi: 10.1073/pnas.1735526100.
14. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M, Feil R. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res. 2014;115:662-667. doi: 10.1161/CIRCRESAHA.115.304634.
15. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, Owens GK. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015;21:628-637. doi: 10.1038/nm.3866.
16. Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM, Fisher EA. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol. 2015;35:535-546. doi: 10.1161/ATVBAHA.114.304029.
17. Huff MW, Pickering JG. Can a vascular smooth muscle-derived foam-cell really change its spots?. Arterioscler Thromb Vasc Biol. 2015;35:492-495. doi: 10.1161/ATVBAHA.115.305225.
18. Cooke PH, Smith SC. Smooth muscle cells: the source of foam cells in atherosclerotic white Carneau pigeons. Exp Mol Pathol. 1968;8:171-189.
19. Bierman EL, Albers JJ. Lipoprotein uptake and degradation by cultured human arterial smooth muscle cells. Adv Exp Med Biol. 1976;67:437-452.
20. Campbell JH, Popadynec L, Nestel PJ, Campbell GR. Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. Atherosclerosis. 1983;47:279-295.
21. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate.I. Changes that lead to fatty streak formation. Arteriosclerosis 1984;4:323-340.
22. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 2014;129:1551-1559. doi: 10.1161/CIRCULATIONAHA.113.005015.
23. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 1973;70:1753-1756.
24. Fisher EA, Miano JM. Don?t judge books by their covers: vascular smooth muscle cells in arterial pathologies. Circulation. 2014;129:1545-1547. doi: 10.1161/CIRCULATIONAHA.114.009075.
25. Chellan B, Reardon CA, Getz GS, Hofmann Bowman MA. Enzymatically modified low-density lipoprotein promotes foam cell formation in smooth muscle cells via macropinocytosis and enhances receptor-mediated uptake of oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2016;36:1101-1113. doi: 10.1161/ATVBAHA.116.307306.
26. Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N, Owens GK. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res. 2007;101:792-801. doi: 10.1161/CIRCRESAHA.107.152736.
27. Ackers-Johnson M, Talasila A, Sage AP, Long X, Bot I, Morrell NW, Bennett MR, Miano JM, Sinha S. Myocardin regulates vascular smooth muscle cell inflammatory activation and disease. Arterioscler Thromb Vasc Biol. 2015;35:817-828. doi: 10.1161/ATVBAHA.114.305218.
28. Kang I, Barth JL, Sproul EP, Yoon DW, Workman GA, Braun KR, Argraves WS, Wight TN. Expression of V3 Versican by rat arterial smooth muscle cells promotes differentiated and anti-inflammatory phenotypes. J Biol Chem. 2015;290:21629-21641. doi: 10.1074/jbc.M115.657486.
29. Beazley KE, Nurminsky D, Lima F, Gandhi C, Nurminskaya MV. Wnt16 attenuates TGFb-induced chondrogenic transformation in vascular smooth muscle. Arterioscler Thromb Vasc Biol. 2015;35:573-579. doi: 10.1161/ATVBAHA.114.304393.
30. Gao C, Fu Y, Li Y, Zhang X, Zhang L, Yu F, Xu SS, Xu Q, Zhu Y, Guan Y, Wang X, Kong W. Microsomal prostaglandin E synthase-1-derived PGE2 inhibits vascular smooth muscle cell calcification. Arterioscler Thromb Vasc Biol. 2016;36:108-121. doi: 10.1161/ATVBAHA.115.306642.
31. Krohn JB, Hutcheson JD, Martínez-Martínez E, Irvin WS, Bouten CV, Bertazzo S, Bendeck MP, Aikawa E. Discoidin domain receptor-1 regulates calcific extracellular vesicle release in vascular smooth muscle cell fibrocalcific response via transforming growth factor-b signaling. Arterioscler Thromb Vasc Biol. 2016;36:525-533. doi: 10.1161/ATVBAHA.115.307009.
32. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593.
33. Zhou J, Zhang M, Fang H, El-Mounayri O, Rodenberg JM, Imbalzano AN, Herring BP. The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2009;29:921-928. doi: 10.1161/ATVBAHA.109.187229.
34. Lu J, Landerholm TE, Wei JS, Dong XR, Wu SP, Liu X, Nagata K, Inagaki M, Majesky MW. Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol. 2001;240:404-418. doi: 10.1006/dbio.2001.0403.
35. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoAmediated actin polymerization. J Biol Chem. 2001;276:341-347. doi: 10.1074/jbc.M005505200.
36. Du KL, Chen M, Li J, Lepore JJ, Mericko P, Parmacek MS. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J Biol Chem. 2004;279:17578-17586. doi: 10.1074/jbc. M400961200.
37. Staus DP, Weise-Cross L, Mangum KD, Medlin MD, Mangiante L, Taylor JM, Mack CP. Nuclear RhoA signaling regulates MRTF-dependent SMCspecific transcription. Am J Physiol Heart Circ Physiol. 2014;307:H379-H390. doi: 10.1152/ajpheart.01002.2013.
38. Copeland JW, Treisman R. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization. Mol Biol Cell. 2002;13:4088-4099. doi: 10.1091/mbc.02-06-0092.
39. Staus DP, Blaker AL, Medlin MD, Taylor JM, Mack CP. Formin homology domain-containing protein 1 regulates smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2011;31:360-367. doi: 10.1161/ATVBAHA.110.212993.
40. Weise-Cross L, Taylor JM, Mack CP. Inhibition of diaphanous formin signaling in vivo impairs cardiovascular development and alters smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2015;35:2374-2383. doi: 10.1161/ATVBAHA.115.305879.
41. Turczynska KM, Swärd K, Hien TT, Wohlfahrt J, Mattisson IY, Ekman M, Nilsson J, Sjögren J, Murugesan V, Hultgårdh-Nilsson A, Cidad P, Hellstrand P, Pérez-García MT, Albinsson S. Regulation of smooth muscle dystrophin and synaptopodin 2 expression by actin polymerization and vascular injury. Arterioscler Thromb Vasc Biol. 2015;35:1489-1497. doi: 10.1161/ATVBAHA.114.305065.
42. Balint B, Yin H, Chakrabarti S, Chu MW, Sims SM, Pickering JG. Collectivization of vascular smooth muscle cells via TGF-b-cadherin-11-dependent adhesive switching. Arterioscler Thromb Vasc Biol. 2015;35:1254-1264. doi: 10.1161/ATVBAHA.115.305310.
43. Thiery JP. Cell adhesion in development: a complex signaling network. Curr Opin Genet Dev. 2003;13:365-371.
44. Fernandez I, Martin-Garrido A, Zhou DW, Clempus RE, Seidel-Rogol B, Valdivia A, Lassègue B, García AJ, Griendling KK, San Martin A. Hic-5 mediates TGFb-induced adhesion in vascular smooth muscle cells by a Nox4-dependent mechanism. Arterioscler Thromb Vasc Biol. 2015;35:1198-1206. doi: 10.1161/ATVBAHA.114.305185.
45. Massagué J. TGFb signalling in context. Nat Rev Mol Cell Biol. 2012;13:616-630. doi: 10.1038/nrm3434.
46. Hu JH, Wei H, Jaffe M, Airhart N, Du L, Angelov SN, Yan J, Allen JK, Kang I, Wight TN, Fox K, Smith A, Enstrom R, Dichek DA. Postnatal deletion of the type II transforming growth factor-b receptor in smooth muscle cells causes severe aortopathy in mice. Arterioscler Thromb Vasc Biol. 2015;35:2647-2656. doi: 10.1161/ATVBAHA.115.306573.
47. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol. 2007;27:1248-1258. doi: 10.1161/ATVBAHA.107.141069.
48. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, Ferruzzi J, Kim RW, Geirsson A, Dietz HC, Offermanns S, Humphrey JD, Tellides G. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest. 2014;124:755-767. doi: 10.1172/JCI69942.
49. Chen X, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Cassis LA, Daugherty A. TGFb neutralization enhances AngII-induced aortic rupture and aneurysm in both thoracic and abdominal regions. PLoS One 2016;11:e0153811. doi: 10.1371/journal.pone.0153811.
50. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789-2800. doi: 10.1016/j.jacc.2009.12.068.
51. Paloschi V, Gådin JR, Khan S, Björck HM, Du L, Maleki S, Roy J, Lindeman JH, Mohamed SA, Tsuda T, Franco-Cereceda A, Eriksson P. Aneurysm development in patients with a bicuspid aortic valve is not associated with transforming growth factor-b activation. Arterioscler Thromb Vasc Biol. 2015;35:973-980. doi: 10.1161/ATVBAHA.114.304996.
52. Gallo EM, Loch DC, Habashi JP, et al. Angiotensin II-dependent TGF-b signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2014;124:448-460. doi: 10.1172/JCI69666.
53. Crosas-Molist E, Meirelles T, López-Luque J, et al. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler Thromb Vasc Biol. 2015;35:960-972. doi: 10.1161/ATVBAHA.114.304412.
54. Wang D, Deuse T, Stubbendorff M, et al. Local MicroRNA modulation using a novel anti-miR-21-eluting stent effectively prevents experimental in-stent restenosis. Arterioscler Thromb Vasc Biol. 2015;35:1945-1953. doi: 10.1161/ATVBAHA.115.305597.
55. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980-984. doi: 10.1038/nature07511.
56. Hartmann D, Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol. 2011;55:92-105. doi: 10.1016/j.vph.2011.07.005.
57. Xu F, Ahmed AS, Kang X, Hu G, Liu F, Zhang W, Zhou J. MicroRNA-15b/16 attenuates vascular neointima formation by promoting the contractile phenotype of vascular smooth muscle through targeting YAP. Arterioscler Thromb Vasc Biol. 2015;35:2145-2152. doi: 10.1161/ATVBAHA.115.305748.
58. Liu F, Wang X, Hu G, Wang Y, Zhou J. The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function. J Biol Chem. 2014;289:3308-3316. doi: 10.1074/jbc. M113.515817.
59. Zeng L, Li Y, Yang J, Wang G, Margariti A, Xiao Q, Zampetaki A, Yin X, Mayr M, Mori K, Wang W, Hu Y, Xu Q. XBP 1-deficiency abrogates neointimal lesion of injured vessels via cross talk with the PDGF signaling. Arterioscler Thromb Vasc Biol. 2015;35:2134-2144. doi: 10.1161/ATVBAHA.115.305420.
60. Williams H, Mill CA, Monk BA, Hulin-Curtis S, Johnson JL, George SJ. Wnt2 and WISP-1/CCN4 induce intimal thickening via promotion of smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 2016;36:1417-1424. doi: 10.1161/ATVBAHA.116.307626.
61. Wight TN. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 2008;13:4933-4937.
62. Kiene LS, Homann S, Suvorava T, et al. Deletion of hyaluronan synthase 3 inhibits neointimal hyperplasia in mice. Arterioscler Thromb Vasc Biol. 2016;36:e9-e16. doi: 10.1161/ATVBAHA.115.306607.
63. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res. 2014;114:1867-1879. doi: 10.1161/CIRCRESAHA.114.302699.
64. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483-493. doi: 10.1111/joim.12406.
65. Gardner SE, Humphry M, Bennett MR, Clarke MC. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1a-dependent senescence-Associated secretory phenotype. Arterioscler Thromb Vasc Biol. 2015;35:1963-1974. doi: 10.1161/ATVBAHA.115.305896.
66. She ZG, Chang Y, Pang HB, Han W, Chen HZ, Smith JW, Stallcup WB. NG2 proteoglycan ablation reduces foam cell formation and atherogenesis via decreased low-density lipoprotein retention by synthetic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2016;36:49-59. doi: 10.1161/ATVBAHA.115.306074.
67. Schwanekamp JA, Lorts A, Vagnozzi RJ, Vanhoutte D, Molkentin JD. Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling. Arterioscler Thromb Vasc Biol. 2016;36:60-68. doi: 10.1161/ATVBAHA.115.306397.
68. Briot A, Jaroszewicz A, Warren CM, Lu J, Touma M, Rudat C, Hofmann JJ, Airik R, Weinmaster G, Lyons K, Wang Y, Kispert A, Pellegrini M, Iruela-Arispe ML. Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. Dev Cell. 2014;31:707-721. doi: 10.1016/j.devcel.2014.11.023.
69. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009;104:733-741. doi: 10.1161/CIRCRESAHA.108.183053.
70. Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y. Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 2015;35:175-183. doi: 10.1161/ATVBAHA.114.304786.
71. Horita H, Wysoczynski CL, Walker LA, Moulton KS, Li M, Ostriker A, Tucker R, McKinsey TA, Churchill ME, Nemenoff RA, Weiser-Evans MC. Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation. Nat Commun. 2016;7:10830. doi: 10.1038/ncomms10830.
72. Shi N, Chen SY. Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases. J Cell Physiol. 2016;231:777-787. doi: 10.1002/jcp.25208.
73. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113:1258-1265. doi: 10.1172/JCI19628.
74. Passman JN, Dong XR, Wu SP, Maguire CT, Hogan KA, Bautch VL, Majesky MW. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci USA. 2008;105:9349-9354. doi: 10.1073/pnas.0711382105.
75. Majesky MW, Dong XR, Hoglund V, Mahoney WM Jr, Daum G. The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol. 2011;31:1530-1539. doi: 10.1161/ATVBAHA.110.221549.
76. Shikatani EA, Chandy M, Besla R, Li CC, Momen A, El-Mounayri O, Robbins CS, Husain M. c-Myb regulates proliferation and differentiation of adventitial Sca1+ vascular smooth muscle cell progenitors by transactivation of myocardin. Arterioscler Thromb Vasc Biol. 2016;36:1367-1376. doi: 10.1161/ATVBAHA.115.307116.
77. Sun Y, Wang K, Ye P, Wu J, Ren L, Zhang A, Huang X, Deng P, Wu C, Yue Z, Chen Z, Ding X, Chen J, Xia J. MicroRNA-155 promotes the directional migration of resident smooth muscle progenitor cells by regulating monocyte chemoattractant protein 1 in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2016;36:1230-1239. doi: 10.1161/ATVBAHA.115.306691.